Scientific Advisory Council

Stanley R. Riddell, MD

Fred Hutchinson Cancer Research Center & University of Washington

Seattle, WA

Dr. Stanley R. Riddell is a full member of the Program in Immunology of the Clinical Research Division at the Fred Hutchinson Cancer Research Center, and a professor of Oncology at the University of Washington.

Dr. Riddell is an expert in cell transplantations and T cell-based immunotherapies and has used them to treat many patients with lymphoma and leukemia. He’s contributed many advances that are widely used in cell-based immunotherapy approaches, including CAR T cells, and also led the first clinical trial that utilized adoptively transferred T cells. He has been elected to the Association of American Physicians, and his current work builds on his previous accomplishments and seeks to identify further ways to improve the effectiveness of T cell immunotherapies.

In addition to being a member of CRI’s Scientific Advisory Council, Dr. Riddell serves on the CLIP Grant Review Committee.

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.